New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


Fishawack Health reorganizes as global commercialization partner for a postpandemic world

UK-based Fishawack Health reorganized business operations as a leading global commercialization partner for the life sciences industry in response to client demand for a more agile, integrated service offering, which is heightened by the pandemic-fueled shifts in the healthcare landscape.


Ironwood Pharma to Halt Development of GERD Drug, Cut 100 Employees

Ironwood Pharmaceuticals initiated an internal organizational restructuring that includes cutting up to 100 full-time employees from payroll following a review of unblinded data from the company’s Phase III trials for IW-3718-302, which show that the drug failed to reduce the severity of heartburn in patients with refractory gastroesophageal reflux disease (GERD).


Women’s Leadership and Mentoring Initiatives Garner Healthcare Businesswomen’s Association Top Honors for BD, GSK, Surgical Care Affiliates and Walgreens Boots Alliance

With global attention on gender and racial inequities this year, the Healthcare Businesswomen’s Association (HBA) is proud to recognize BD (Becton, Dickinson and Company) GSK, Surgical Care Affiliates and Walgreens Boots Alliance with 2020 ACE Awards for exemplary workplace initiatives that are working to close the gender and racial inequities in the healthcare and life sciences industry.


Oxford to study anti-inflammatory drug Humira as potential Covid-19 treatment

Oxford University will study whether the world’s best-selling prescription medicine adalimumab was an effective treatment for Covid-19 patients in the latest effort to repurpose existing drugs as potential coronavirus therapies.


Moderna Covid-19 vaccine appears safe, shows signs of working in older adults – study

Results from an early safety study of Moderna Inc.’s coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots, researchers said.